search
Back to results

Evaluation of Central Macular Thickness in Femtosecond Laser-assisted Cataract Surgery (FLAME)

Primary Purpose

Age Related Cataracts, Cystoid Macular Edema

Status
Unknown status
Phase
Not Applicable
Locations
Austria
Study Type
Interventional
Intervention
Femtosecond Laser
Manual Cataract Surgery
Sponsored by
Medical University of Vienna
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional diagnostic trial for Age Related Cataracts

Eligibility Criteria

40 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Bilateral Age-related cataract necessitating lens extraction and posterior IOL implantation
  • Age 40 and older (females of childbearing age will be interviewed if pregnancy is possible)

Exclusion Criteria:

  • Corneal abnormality
  • Preceding ocular surgery or trauma
  • Uncontrolled glaucoma
  • Proliferative diabetic retinopathy
  • Macular degeneration
  • Iris neovascularization
  • History of uveitis/iritis
  • Microphthalmus
  • Recurrent intraocular inflammation of unknown etiology
  • Blind fellow eye
  • Uncontrolled systemic or ocular disease

Sites / Locations

  • Medical University of Vienna

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Active Comparator

Arm Label

Femtosecond Laser assisted Cataract Surgery

Manual Cataract Surgery

Arm Description

Femtosecond Laser assisted Cataract Surgery will be performed unilateral in randomized order.

Manual Cataract Surgery will be performed in contralateral (to LCS) eye of patient with bilateral age-related cataract.

Outcomes

Primary Outcome Measures

Central Macular Thickness
Difference in Central Macular Thickness (CMT) between Femtosecond Laser-assisted Cataract Surgery (LCS) to Manual Cataract Surgery (MCS)

Secondary Outcome Measures

Influence of lens density on quantitative autofluorescence
Influence of lens density on quantitative autofluorescence will be assessed in qAF units. Images will be recorded after volume scans for each eye on designated visits. Quantitative Autofluorescence quantifies natural fundus autofluorescence with a Spectralis HRA+OCT. This method uses the same wavelength and confocal scanning laser ophthalmoscope as fundus autofluorescence (488nm; maximum power: 280 µW) and can be used to determine the integrity and vitality of the retinal pigment epithelium which is important for nourishment the retina.
Central Macular Thickness
Difference in Central Macular Thickness (CMT) between Femtosecond Laser-assisted Cataract Surgery (LCS) to Manual Cataract Surgery (MCS)

Full Information

First Posted
March 1, 2018
Last Updated
March 6, 2019
Sponsor
Medical University of Vienna
search

1. Study Identification

Unique Protocol Identification Number
NCT03465124
Brief Title
Evaluation of Central Macular Thickness in Femtosecond Laser-assisted Cataract Surgery
Acronym
FLAME
Official Title
Evaluation of Central Macular Thickness in Femtosecond Laser-assisted Cataract Surgery - FLAME
Study Type
Interventional

2. Study Status

Record Verification Date
March 2019
Overall Recruitment Status
Unknown status
Study Start Date
March 26, 2018 (Actual)
Primary Completion Date
February 19, 2019 (Actual)
Study Completion Date
April 6, 2019 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Medical University of Vienna

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The investigational device is an approved femtosecond laser (FSL) device with an integrated imaging system to perform certain steps of the cataract procedure. The FSL will perform anterior capsulotomy and lens fragmentation in individuals suffering from age-related cataract with need of cataract surgery. Cataract surgery will be performed in subjects who have signed an informed consent form. Macula thickness will be measured with Spectralis OCT on screening date. Postoperative examinations will be implemented in accordance with the approved investigational plan on subjects and includes: visual acuity, slitlamp examination, retinal oct imaging and quantitative autofluorescence.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Age Related Cataracts, Cystoid Macular Edema

7. Study Design

Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Bilateral cataract surgery will be performed in individuals with age-related cataract. Eyes will be randomized into two groups receiving either Femtosecond Laser assisted Cataract Surgery (LCS) or conventional Manual Cataract Surgery (MCS).
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Masking Description
Groups will be randomized. Randomization information will be put in a sealed envelope on screening date and opened in operating theatre right before procedure start.
Allocation
Randomized
Enrollment
60 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Femtosecond Laser assisted Cataract Surgery
Arm Type
Active Comparator
Arm Description
Femtosecond Laser assisted Cataract Surgery will be performed unilateral in randomized order.
Arm Title
Manual Cataract Surgery
Arm Type
Active Comparator
Arm Description
Manual Cataract Surgery will be performed in contralateral (to LCS) eye of patient with bilateral age-related cataract.
Intervention Type
Device
Intervention Name(s)
Femtosecond Laser
Intervention Description
Femtosecond Laser assisted Cataract Surgery will be performed unilateral in randomized order. Contralateral eye will receive conventional cataract surgery
Intervention Type
Other
Intervention Name(s)
Manual Cataract Surgery
Intervention Description
conventional cataract surgery as control
Primary Outcome Measure Information:
Title
Central Macular Thickness
Description
Difference in Central Macular Thickness (CMT) between Femtosecond Laser-assisted Cataract Surgery (LCS) to Manual Cataract Surgery (MCS)
Time Frame
Baseline to 6 weeks postoperative
Secondary Outcome Measure Information:
Title
Influence of lens density on quantitative autofluorescence
Description
Influence of lens density on quantitative autofluorescence will be assessed in qAF units. Images will be recorded after volume scans for each eye on designated visits. Quantitative Autofluorescence quantifies natural fundus autofluorescence with a Spectralis HRA+OCT. This method uses the same wavelength and confocal scanning laser ophthalmoscope as fundus autofluorescence (488nm; maximum power: 280 µW) and can be used to determine the integrity and vitality of the retinal pigment epithelium which is important for nourishment the retina.
Time Frame
Baseline to 1 weel, 3 weeks and 6 weeks postoperative
Title
Central Macular Thickness
Description
Difference in Central Macular Thickness (CMT) between Femtosecond Laser-assisted Cataract Surgery (LCS) to Manual Cataract Surgery (MCS)
Time Frame
Baseline to 1 week, 3 weeks, 6 weeks postoperative

10. Eligibility

Sex
All
Minimum Age & Unit of Time
40 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Bilateral Age-related cataract necessitating lens extraction and posterior IOL implantation Age 40 and older (females of childbearing age will be interviewed if pregnancy is possible) Exclusion Criteria: Corneal abnormality Preceding ocular surgery or trauma Uncontrolled glaucoma Proliferative diabetic retinopathy Macular degeneration Iris neovascularization History of uveitis/iritis Microphthalmus Recurrent intraocular inflammation of unknown etiology Blind fellow eye Uncontrolled systemic or ocular disease
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Rupert Menapace, MD
Organizational Affiliation
Medical Universitiy of Vienna
Official's Role
Principal Investigator
Facility Information:
Facility Name
Medical University of Vienna
City
Vienna
ZIP/Postal Code
1090
Country
Austria

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
34135449
Citation
Reiter GS, Schwarzenbacher L, Schartmuller D, Roggla V, Leydolt C, Menapace R, Schmidt-Erfurth U, Sacu S. Influence of lens opacities and cataract severity on quantitative fundus autofluorescence as a secondary outcome of a randomized clinical trial. Sci Rep. 2021 Jun 16;11(1):12685. doi: 10.1038/s41598-021-92309-6.
Results Reference
derived

Learn more about this trial

Evaluation of Central Macular Thickness in Femtosecond Laser-assisted Cataract Surgery

We'll reach out to this number within 24 hrs